(Q77676174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

B Ferger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Spratt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Teismann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Seitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K Kuschinsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

155-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Decreased ferritin levels in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Effects of alpha-phenyl-tert-butylnitrone and selegiline on hydroxyl free radicals in rat striatum produced by local application of glutamate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Altered systemic iron metabolism in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Intranigral injected iron progressively reduces striatal dopamine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

The possible role of iron in the etiopathology of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900696-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00696-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851582%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference